NEW YORK, Oct. 30, 2018 /PRNewswire/ -- ARYA Sciences
Acquisition Corp. (the "Company") (NASDAQ: ARYAU) today announced
that the holders of the Company's units may elect to separately
trade the Class A ordinary shares and warrants underlying the
units commencing on November 2, 2018.
No fractional warrants will be issued upon separation of the units
and only whole warrants will trade. Those units not separated will
continue to trade on The Nasdaq Capital Market under the symbol
"ARYAU," and the Class A ordinary shares and the warrants are
expected to trade under the symbols "ARYA" and "ARYAW,"
respectively. Holders of units will need to have their brokers
contact Continental Stock Transfer & Trust Company, the
Company's transfer agent, in order to separate the units into
shares of Class A ordinary shares and warrants.
The units were initially offered by the Company in an
underwritten offering. Jefferies LLC acted as the sole book-running
manager and Chardan acted as the lead manager for the offering.
A registration statement relating to the units and the
underlying securities was declared effective by the Securities and
Exchange Commission on October 4,
2018.
This press release shall not constitute an offer to sell nor the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction. A copy of the final prospectus relating to the
offering may be obtained for free by visiting the U.S. Securities
and Exchange Commission website at
http://www.sec.gov. Alternatively, a copy of the final
prospectus relating to the offering may be obtained from Jefferies
LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison
Avenue, 2nd Floor, New York,
New York 10022, or by telephone at 877-547-6340, or by email
at Prospectus_Department@Jefferies.com.
About ARYA
The Company is a newly organized blank
check company newly incorporated as a Cayman Islands exempted company for the
purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with
one or more businesses or entities. The Company has not selected
any business combination target and we have not, nor has anyone on
our behalf, initiated any substantive discussions, directly or
indirectly, with respect to identifying any business combination
target.
Forward-Looking Statements
This press release includes forward-looking statements that involve
risks and uncertainties. Forward-looking statements are statements
that are not historical facts. Such forward-looking statements,
including the successful consummation of the Company's initial
public offering, are subject to risks and uncertainties, which
could cause actual results to differ from the forward-looking
statements. The Company expressly disclaims any obligations or
undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change
in the Company's expectations with respect thereto or any change in
events, conditions or circumstances on which any statement is
based.
Contact
Michael Altman
Chief Financial Officer of ARYA Sciences Acquisition Corp.
(646) 205-5300
ARYA@perceptivelife.com
View original
content:http://www.prnewswire.com/news-releases/arya-sciences-acquisition-corp-to-commence-separate-trading-of-its-class-a-ordinary-shares-and-warrants-on-november-2-2018-300740790.html
SOURCE ARYA Sciences Acquisition Corp.